Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Fri, 19.01.2024
MediClin AG
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014Offenburg, January 19, 2024MEDICLIN close to the sale of Herzzentrum Coswig; impairment losses lead to new, adjusted forecast for 2023 MEDICLIN Aktiengesellschaft (“MEDICLIN”) is on the final stage of selling the MEDICLIN Herzzentrum Coswig, Coswig. An agre [ … ]
Fri, 19.01.2024
Nordea Bank Abp
Nordea Bank Abp
/ Key word(s): Transaction in Own Shares
Transaction in Own Shares
19.01.2024 / 08:35 CET/CEST
Nordea Bank Abp: Repurchase of own shares on 18.01.2024
Nordea Bank Abp
Stock exchange release - Changes in company's own shares
18.01.2024 at 22.30 EET
Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 18.0 [ … ]
Fri, 19.01.2024
INFICON Holding AG
INFICON Holding AG
/ Key word(s): Acquisition
INFICON Acquires all Assets of Smart Manufacturing Software Specialist FabTime 19.01.2024 / 08:25 CET/CEST
Corporate Contact
Matthias Tröndle
Chief Financial Officer
+423 388 3510 matthias.troendle@inficon.com
Announcement of INFICON Holding AGBad Ragaz/Switzerland, January 19, 2 [ … ]
Fri, 19.01.2024
Dexus Finance Pty Limited
Dexus (ASX: DXS)
ASX release
19 January 2024
ASX announcements
Dexus today announced the following ASX announcements.
Appendix 3Y - Change of Director's Interest Notice for Darren Steinberg
Appendix 3G - Appendix 3G - Notification regarding unquoted securities
Appendix 3G - Appendix 3G - Notification regarding unquoted securities
Appendix [ … ]
Fri, 19.01.2024
BASF SE
BASF Group releases preliminary figures for full year 2023
Sales and EBIT before special items below the ranges forecasted by BASF and slightly below the respective analyst consensus
EBIT and net income considerably below the respective analyst consensus due to non-cash-effective impairments
Cash flows from operating activities above prior year
[ … ]
Fri, 19.01.2024
Crealogix Holding AG
Following the end of the main offer period, VENCORA UK Limited has published the provisional notice of the interim result of its public tender offer for all publicly held registered shares in CREALOGIX Holding AG with a nominal value of CHF 8.00 each. The provisional notice of the interim result shows that, based on preliminary figures, 622,800 CRE [ … ]
Fri, 19.01.2024
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
January 19, 2024
BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information:
Results for the financial year 2023
Based on its preliminary unaudited [ … ]
Fri, 19.01.2024
BB BIOTECH AG
Media release as at January 19, 2024
Portfolio of BB Biotech AG as at December 31, 2023
End of year biotech equity market rally – M&A and end of rate hike cycle
In 2023, global equity performed better than anticipated by many. The US central bank moderated and then paused interest rate hikes. These developments resulted in a year-end bond ma [ … ]
Fri, 19.01.2024
Zehnder Group AG
Group sales decreased by 6% to EUR 762.1 million
Acquisitions and price increases had a positive effect on revenue; declining volumes had a growing negative impact on sales in the second half of the year
The full annual financial statements for 2023 will be published on 28 February 2024
Graenichen (CH), 19 January 2024: Zehnder Group (SIX: ZEHN), [ … ]
Fri, 19.01.2024
SFS Group Schweiz AG
The SFS Group achieved its defined growth targets despite a difficult economic environment. In financial year 2023, third-party sales of CHF 3,090.8 million were generated. The again strong increase of 12.6% against the prior-year period was underpinned by robust organic growth of 2.1%. Consolidation effects stemming from the inclusion of Hoffmann [ … ]